Hormonal composition and its use
US9084796B2 · kind B2 · utility
0Cited by
19References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 17, 2012 |
| Grant date | Jul 21, 2015 |
| Priority date | — |
| Expiry date | Apr 17, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P19/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of preventing estrogen deficiencies and osteoporosis in menopausal women by continuously orally administering without interruption to menopausal women in need thereof an amount of 0.3 to 3 mg of 17β-estradiol or esters thereof and 0.3 to 1.25 mg of nomegestrol or esters thereof in an amount sufficient to prevent said problems.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.